Shigella dysenteriae type 1 O-antigen polysaccharide (SD1 O-antigen)

The Shigella dysenteriae type 1 O-antigen polysaccharide is a critical component of the lipopolysaccharide (LPS) found on the outer membrane of this Gram-negative bacterium. It consists of a repeating tetrasaccharide unit comprising L-rhamnose, D-galactose, and N-acetyl-D-glucosamine, which defines the serological specificity of the organism (PubMed: 10417340). This molecule plays a vital role in bacterial virulence by protecting the pathogen from the host's innate immune system, specifically by preventing complement-mediated lysis and aiding in epithelial cell invasion (PubMed: 16214598). Because S. dysenteriae type 1 is the primary cause of epidemic bacillary dysentery and is associated with severe complications like Hemolytic Uremic Syndrome, its O-antigen is a major target for vaccine development (NIH: PMC3122497). Therapeutic strategies focus on conjugate vaccines, where the O-polysaccharide is chemically linked to carrier proteins to induce long-lasting, T-cell dependent immune responses (PubMed: 10417340). Additionally, monoclonal antibodies targeting this specific polysaccharide are being explored for passive immunization and diagnostic purposes (PubMed: 25156724).

Other names

Shigella dysenteriae serotype 1 O-specific polysaccharideSD1 O-SPO-antigen of Shigella dysenteriae type 1Lipopolysaccharide O-side chain

Induction of protective humoral immunity through the production of serotype-specific antibodies that facilitate opsonophagocytosis and complement-mediated killing of the bacteria.